Background and Target Overview

Phospholipase A2 Activator Protein (PLAA) is an intracellular protein that plays a role in activating phospholipase A2 (PLA2) enzymes, which catalyze the hydrolysis of glycerophospholipids to release arachidonic acid and lysophospholipids. Arachidonic acid subsequently serves as a precursor for the biosynthesis of eicosanoids including prostaglandins, thromboxanes, and leukotrienes, making PLAA an important node in inflammatory and lipid-signaling pathways.

PLAA has also been implicated in ubiquitin-mediated protein degradation pathways, where it interacts with components of the 26S proteasome. Research into PLAA expression and function is therefore relevant to inflammation, cellular stress responses, and neurodegenerative disease models.

The Phospholipase A2 Activator Protein Mouse mAb (Ab351030) provides a specific tool for detecting endogenous PLAA in relevant experimental systems.

Reagent Preparation and Storage

Formulation: This antibody is supplied in PBS (Phosphate-Buffered Saline) only, without carrier proteins or preservatives unless otherwise stated on the vial label. Researchers should verify the exact buffer composition on the Certificate of Analysis (CoA) provided with each lot.

Recommended Storage Conditions:

• Store at −20°C for long-term storage to maintain antibody activity.
• For short-term use (up to 1 month), aliquots may be kept at 4°C.
• Avoid repeated freeze-thaw cycles, which can denature the antibody and reduce specific activity. Prepare single-use aliquots upon first thaw.
• Do not store at room temperature for extended periods.

Reconstitution (if supplied lyophilized): If the product is received in lyophilized form, reconstitute in the volume of sterile ultrapure water or PBS indicated on the vial label. Allow the vial to equilibrate to room temperature before opening, and mix gently without vortexing.

Note: Confirm the supplied state (liquid vs. lyophilized) from the product label and CoA, as formulation details for this lot reference absea#KC-46749 indicate a PBS-only liquid format.

Recommended Protocol Steps

The following general protocol is intended as a starting guide. Optimal conditions should be empirically determined for each laboratory's specific application and sample type.

1. Sample Preparation: Prepare cell lysates or tissue homogenates under non-denaturing or denaturing conditions as required by the application. For Western blot, use standard SDS-PAGE sample buffer and boil samples at 95°C for 5 minutes. For immunofluorescence or IHC, fix samples with 4% paraformaldehyde or as appropriate for antigen retrieval compatibility.
2. Blocking: Block non-specific binding sites with 5% non-fat dried milk in TBST (for Western blot) or 5% normal serum in PBS-T (for IHC/IF) for 60 minutes at room temperature.
3. Primary Antibody Incubation: Dilute the Phospholipase A2 Activator Protein Mouse mAb (Ab351030) in blocking buffer. Recommended starting dilutions are 1:500–1:2000 for Western blot; optimize empirically for IHC, IF, and ELISA. Incubate overnight at 4°C with gentle agitation.
4. Washing: Wash three times for 10 minutes each with TBST or PBS-T to remove unbound antibody.
5. Secondary Antibody Incubation: Apply an appropriate HRP- or fluorophore-conjugated anti-mouse secondary antibody. Incubate for 60 minutes at room temperature. Wash again three times as above.
6. Detection: Detect signal using ECL reagent (Western blot), DAB substrate (IHC), or appropriate fluorescence imaging system (IF).
7. Analysis: Analyze band size, staining pattern, or signal intensity relative to controls to confirm specific PLAA detection.

Note: Specific dilutions, incubation times, and antigen retrieval methods should be validated per the researcher's experimental system. Positive and negative controls are strongly recommended.

Troubleshooting and Optimization Tips

If unexpected results are obtained, consider the following common troubleshooting strategies:

• No signal or weak signal: Increase primary antibody concentration; extend incubation time; verify that secondary antibody is anti-mouse; confirm sample contains PLAA-expressing cells or tissue. Check that the antibody was not subjected to excessive freeze-thaw cycles.
• High background: Increase washing steps and duration; increase blocking stringency; reduce primary antibody concentration; ensure PBS is free of azide if using HRP-based detection.
• Non-specific bands (Western blot): Optimize antibody dilution; increase blocking with BSA; confirm gel percentage is appropriate for PLAA molecular weight.
• Inconsistent results between lots: Always titrate new lots independently; request a CoA and compare reactivity data; contact Aladdin Scientific technical support for lot-specific guidance.
• Antigen retrieval (IHC): If staining is absent in formalin-fixed paraffin-embedded (FFPE) tissue, try heat-induced epitope retrieval (HIER) with citrate buffer (pH 6.0) or EDTA buffer (pH 9.0).

Safety, Handling, and Disposal

Safety Precautions: This product is intended for research use only (RUO) and is not approved for diagnostic or therapeutic use in humans or animals. Handle all biological reagents according to your institution's biosafety guidelines.

Personal Protective Equipment (PPE): Wear appropriate laboratory PPE including gloves, lab coat, and eye protection when handling this reagent.

Spill Management: In the event of a spill, absorb with inert material and dispose of according to local regulations for biological waste.

Disposal: Dispose of unused reagent and contaminated materials in accordance with applicable local, national, and institutional regulations for biological and chemical waste. Do not pour antibody solutions down the drain without prior deactivation as required by your institution.

SDS: Refer to the Safety Data Sheet (SDS) provided by Aladdin Scientific for complete hazard information specific to this product.